Review




Structured Review

Creative Bioarray Inc h1339 human sclc cell line
H1339 Human Sclc Cell Line, supplied by Creative Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/h1339 human sclc cell line/product/Creative Bioarray Inc
Average 90 stars, based on 1 article reviews
h1339 human sclc cell line - by Bioz Stars, 2026-03
90/100 stars

Images



Similar Products

90
Creative Bioarray Inc h1339 human sclc cell line
H1339 Human Sclc Cell Line, supplied by Creative Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/h1339 human sclc cell line/product/Creative Bioarray Inc
Average 90 stars, based on 1 article reviews
h1339 human sclc cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
DSMZ human lung cancer cell lines h1339 (sclc)
Human Lung Cancer Cell Lines H1339 (Sclc), supplied by DSMZ, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung cancer cell lines h1339 (sclc)/product/DSMZ
Average 90 stars, based on 1 article reviews
human lung cancer cell lines h1339 (sclc) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
DSMZ human sclc cell line h1339
<t>H1339</t> human small cell lung cancer cells were exposed to 0.5 μg/ml cisplatin for 3 h . The cells that had survived were allowed to recover for 7 days and were again exposed to 0.5 μg/ml cisplatin. After 4
Human Sclc Cell Line H1339, supplied by DSMZ, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human sclc cell line h1339/product/DSMZ
Average 90 stars, based on 1 article reviews
human sclc cell line h1339 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


H1339 human small cell lung cancer cells were exposed to 0.5 μg/ml cisplatin for 3 h . The cells that had survived were allowed to recover for 7 days and were again exposed to 0.5 μg/ml cisplatin. After 4

Journal: European Journal of Medical Research

Article Title: Reduced expression of Bax in small cell lung cancer cells is not sufficient to induce cisplatin-resistance

doi: 10.1186/2047-783X-15-10-448

Figure Lengend Snippet: H1339 human small cell lung cancer cells were exposed to 0.5 μg/ml cisplatin for 3 h . The cells that had survived were allowed to recover for 7 days and were again exposed to 0.5 μg/ml cisplatin. After 4 "cycles", the survival after a 5th exposure was compared to the survival of naïve cells. Pre-treated cells showed an increased survival fraction compared to naïve cell (* = P < 0.01).

Article Snippet: The human SCLC cell line H1339 was purchased from DSMZ, Braunschweig, Germany.

Techniques:

The expression of members of the Bcl-2 family of proteins was studied in naïve and resistant H1339 cells using Western Blot . (A) The expression of Bax was lower in resistant cells (n = 3, P < 0.05) while the expression of Bad, Bim and Bid showed no difference. (B) Representative Western Blots.

Journal: European Journal of Medical Research

Article Title: Reduced expression of Bax in small cell lung cancer cells is not sufficient to induce cisplatin-resistance

doi: 10.1186/2047-783X-15-10-448

Figure Lengend Snippet: The expression of members of the Bcl-2 family of proteins was studied in naïve and resistant H1339 cells using Western Blot . (A) The expression of Bax was lower in resistant cells (n = 3, P < 0.05) while the expression of Bad, Bim and Bid showed no difference. (B) Representative Western Blots.

Article Snippet: The human SCLC cell line H1339 was purchased from DSMZ, Braunschweig, Germany.

Techniques: Expressing, Western Blot

The expression of Bax was assessed in naïve and resistant H1339 cells using immuno-fluorescence and found to be lower in resistant cells (n = 20, P < 0.01) .

Journal: European Journal of Medical Research

Article Title: Reduced expression of Bax in small cell lung cancer cells is not sufficient to induce cisplatin-resistance

doi: 10.1186/2047-783X-15-10-448

Figure Lengend Snippet: The expression of Bax was assessed in naïve and resistant H1339 cells using immuno-fluorescence and found to be lower in resistant cells (n = 20, P < 0.01) .

Article Snippet: The human SCLC cell line H1339 was purchased from DSMZ, Braunschweig, Germany.

Techniques: Expressing, Fluorescence

A Naïve H1339 cells were 48 h treated with 10 μM siRNA targeting Bax . As a result, the expression of Bax was reduced compared to naïve cells treated with non-targeting RNA. B Naïve H1339 cells with a reduced expression of Bax (naïve siRNA) and sham treated naïve H1339 cells (naïve ntRNA) were exposed to 0.5 μg/ml cisplatin for 3 h. No difference in the cisplatin-sensitivity could be observed.

Journal: European Journal of Medical Research

Article Title: Reduced expression of Bax in small cell lung cancer cells is not sufficient to induce cisplatin-resistance

doi: 10.1186/2047-783X-15-10-448

Figure Lengend Snippet: A Naïve H1339 cells were 48 h treated with 10 μM siRNA targeting Bax . As a result, the expression of Bax was reduced compared to naïve cells treated with non-targeting RNA. B Naïve H1339 cells with a reduced expression of Bax (naïve siRNA) and sham treated naïve H1339 cells (naïve ntRNA) were exposed to 0.5 μg/ml cisplatin for 3 h. No difference in the cisplatin-sensitivity could be observed.

Article Snippet: The human SCLC cell line H1339 was purchased from DSMZ, Braunschweig, Germany.

Techniques: Expressing